type: pattern tags: [deceleration, revenue-growth, dollar-adds, yoy-compression, scale, denominator-effect] confidence: high created: 2026-03-27 updated: 2026-03-31 source: HNGE stock-analysis 2026-03 persona: wsm provenance: legacy source_analysis_path: null source_paragraph_quote: null source_transcript_span: null source_loss_log_path: null

Dollar-Add Stability as True Growth Signal vs. YoY% Deceleration

At high-growth companies reaching scale ($500M+), YoY percentage deceleration can be purely mathematical — the denominator is growing faster than the business can outrun it. Absolute quarterly dollar adds remaining flat or growing while YoY% compresses is the correct signal of underlying demand health. These are not the same event and should not trigger the same analytical response.

Evidence

• HNGE Q2-Q4 FY25: incremental quarterly revenue adds were $15.3M, $15.1M, $16.5M — perfectly stable, slightly accelerating.
• Over that same period, YoY% compressed from 54.9% → 53.3% → 45.5% — a full 9pp deceleration on the headline.
• The compression was entirely denominator-driven: Q2 FY24 was $89.8M, Q4 FY24 was $117.3M (a $27.5M QoQ jump) — a large base that mechanically depresses YoY% even with constant dollar adds.
• MNDY FY24-FY25: incremental quarterly revenue adds were $14.3M, $19.2M, $14.9M, $17.0M, $14.3M, $16.8M, $17.8M, $17.0M — stable in a $14-19M band for 8 consecutive quarters. Over the same period, YoY% compressed from ~32% to ~25%. The headline deceleration narrative drove the stock down ~70% from highs; the dollar-add stability signal contradicted persistent demand deterioration throughout.

Implication

Before flagging YoY deceleration as a thesis risk, compute the sequential dollar add trend over 3+ quarters. If dollar adds are stable or growing, the "deceleration" is mathematical scale compression, not demand softening. Reserve concern for cases where dollar adds are also declining — that signals actual growth degradation. Build a dollar-add column into every revenue table. The pattern now confirmed across at least two distinct companies and sectors.